Exact Mass: 433.2285
Exact Mass Matches: 433.2285
Found 500 metabolites which its exact mass value is equals to given mass value 433.2285
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Mycophenolate mofetil
Mycophenolate mofetil is only found in individuals that have used or taken this drug. It is the 2-morpholinoethyl ester of mycophenolic acid (MPA), an immunosuppressive agent, inosine monophosphate dehydrogenase (IMPDH) inhibitor.Mycophenolate mofetil is hydrolyzed to form mycophenolic acid (MPA), which is the active metabolite. MPA is a potent, selective, uncompetitive, and reversible inhibitor of inosine monophosphate dehydrogenase (IMPDH), and therefore inhibits the de novo pathway of guanosine nucleotide synthesis without incorporation into DNA. Because T- and B-lymphocytes are critically dependent for their proliferation on de novo synthesis of purines, whereas other cell types can utilize salvage pathways, MPA has potent cytostatic effects on lymphocytes. MPA inhibits proliferative responses of T- and B-lymphocytes to both mitogenic and allospecific stimulation. Addition of guanosine or deoxyguanosine reverses the cytostatic effects of MPA on lymphocytes. MPA also suppresses antibody formation by B-lymphocytes. MPA prevents the glycosylation of lymphocyte and monocyte glycoproteins that are involved in intercellular adhesion to endothelial cells and may inhibit recruitment of leukocytes into sites of inflammation and graft rejection. Mycophenolate mofetil did not inhibit early events in the activation of human peripheral blood mononuclear cells, such as the production of interleukin-1 (IL-1) and interleukin-2 (IL-2), but did block the coupling of these events to DNA synthesis and proliferation. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors
Paspalinine
Hericenone B
Hericenone B is found in mushrooms. Hericenone B is isolated from the edible lions mane mushroom (Hericium erinaceum). Isolated from the edible lions mane mushroom (Hericium erinaceum). Hericenone B is found in mushrooms.
Dextrorphan O-glucuronide
Dextrorphan O-glucuronide is a natural human metabolite of Dextrorphan generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Dextrorphan O-glucuronide is a natural human metabolite of Dextrorphan generated in the liver by UDP glucuonyltransferase.
Ricolinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
(Z)-1-[4-(4-Diethylaminobutoxy)phenyl]-1,2-diphenyl-2-chloro-ethylene
6-(4-Hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-4-hexenoic acid 2-(4-morpholinyl)ethyl ester
Ilicicolin H
An aromatic ketone in which the ketone carbonyl group is attached to a (1R,2R,4aS,7S,8aR)-4,7-dimethyl-1-[(1E)-prop-1-en-1-yl]-1,2,4a,5,6,7,8,8a-octahydronaphthalen-2-yl group and a 4-hydroxy-5-(4-hydroxyphenyl)-2-oxo-1,2-dihydropyridin-3-yl group. Isolated from the from the "imperfect" fungus Cylindrocladium iliciola strain MFC-870.
nortropane-3alpha,7beta-diol 3-(2-methylpropanoate) 7-cis-(3,4,5-trimethoxycinnamate)
(3S,8aS)-3-((7,7-dimethyl-2-(2-methylbut-3-en-2-yl)-1,7-dihydropyrano[2,3-g]indol-3-yl)methyl)-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione|notoamide E
C26H31N3O3_Pyrrolo[1,2-a]pyrazine-1,4-dione, 3-[[7-(1,1-dimethyl-2-propen-1-yl)-2,8-dihydro-2,2-dimethylpyrano[3,2-f]indol-6-yl]methyl]hexahydro
Notoamide E
A pyranoindole that is notoamide S in which the phenolic hydrosy group at position 6 of the indole moiety has formal addition to the 3-methylbut-2-en-1-yl group at postion 7 of the indole moiety to give the corresponding 7,7-dimethyl-1,7-dihydropyrano[2,3-g]indole derivative. Isolated from a mussel-derived Aspergillus species.
Ala Cys Ile Lys
Ala Cys Lys Ile
Ala Cys Lys Leu
Ala Cys Leu Lys
Ala Asp Lys Thr
Ala Asp Thr Lys
Ala Glu Lys Ser
Ala Glu Ser Lys
Ala Gly Met Arg
Ala Gly Arg Met
Ala Ile Cys Lys
Ala Ile Lys Cys
Ala Lys Cys Ile
Ala Lys Cys Leu
Ala Lys Asp Thr
Ala Lys Glu Ser
Ala Lys Ile Cys
Ala Lys Leu Cys
Ala Lys Ser Glu
Ala Lys Thr Asp
Ala Leu Cys Lys
Ala Leu Lys Cys
Ala Met Gly Arg
Ala Met Arg Gly
Ala Arg Gly Met
Ala Arg Met Gly
Ala Arg Ser Thr
Ala Arg Thr Ser
Ala Ser Glu Lys
Ala Ser Lys Glu
Ala Ser Arg Thr
Ala Ser Thr Arg
Ala Thr Asp Lys
Ala Thr Lys Asp
Ala Thr Arg Ser
Ala Thr Ser Arg
Cys Ala Ile Lys
Cys Ala Lys Ile
Cys Ala Lys Leu
Cys Ala Leu Lys
Cys Gly Arg Val
Cys Gly Val Arg
Cys Ile Ala Lys
Cys Ile Lys Ala
Cys Lys Ala Ile
Cys Lys Ala Leu
Cys Lys Ile Ala
Cys Lys Leu Ala
Cys Leu Ala Lys
Cys Leu Lys Ala
Cys Arg Gly Val
Cys Arg Val Gly
Cys Val Gly Arg
Cys Val Arg Gly
Asp Ala Lys Thr
Asp Ala Thr Lys
Asp Lys Ala Thr
Asp Lys Thr Ala
Asp Thr Ala Lys
Asp Thr Lys Ala
Glu Ala Lys Ser
Glu Ala Ser Lys
Glu Gly Lys Thr
Glu Gly Thr Lys
Glu Lys Ala Ser
Glu Lys Gly Thr
Glu Lys Ser Ala
Glu Lys Thr Gly
Glu Ser Ala Lys
Glu Ser Lys Ala
Glu Thr Gly Lys
Glu Thr Lys Gly
Gly Ala Met Arg
Gly Ala Arg Met
Gly Cys Arg Val
Gly Cys Val Arg
Gly Glu Lys Thr
Gly Glu Thr Lys
Gly Lys Glu Thr
Gly Lys Met Val
Gly Lys Thr Glu
Gly Lys Val Met
Gly Met Ala Arg
Gly Met Lys Val
Gly Met Arg Ala
Gly Met Val Lys
Gly Arg Ala Met
Gly Arg Cys Val
Gly Arg Met Ala
Gly Arg Thr Thr
Gly Arg Val Cys
Gly Thr Glu Lys
Gly Thr Lys Glu
Gly Thr Arg Thr
Gly Thr Thr Arg
Gly Val Cys Arg
Gly Val Lys Met
Gly Val Met Lys
Gly Val Arg Cys
Ile Ala Cys Lys
Ile Ala Lys Cys
Ile Cys Ala Lys
Ile Cys Lys Ala
Ile Lys Ala Cys
Ile Lys Cys Ala
Ile Asn Ser Thr
Ile Asn Thr Ser
Ile Gln Ser Ser
Ile Ser Asn Thr
Ile Ser Gln Ser
Ile Ser Ser Gln
Ile Ser Thr Asn
Ile Thr Asn Ser
Ile Thr Ser Asn
Lys Ala Cys Ile
Lys Ala Cys Leu
Lys Ala Asp Thr
Lys Ala Glu Ser
Lys Ala Ile Cys
Lys Ala Leu Cys
Lys Ala Ser Glu
Lys Ala Thr Asp
Lys Cys Ala Ile
Lys Cys Ala Leu
Lys Cys Ile Ala
Lys Cys Leu Ala
Lys Asp Ala Thr
Lys Asp Thr Ala
Lys Glu Ala Ser
Lys Glu Gly Thr
Lys Glu Ser Ala
Lys Glu Thr Gly
Lys Gly Glu Thr
Lys Gly Met Val
Lys Gly Thr Glu
Lys Gly Val Met
Lys Ile Ala Cys
Lys Ile Cys Ala
Lys Leu Ala Cys
Lys Leu Cys Ala
Lys Met Gly Val
Lys Met Val Gly
Lys Ser Ala Glu
Lys Ser Glu Ala
Lys Thr Ala Asp
Lys Thr Asp Ala
Lys Thr Glu Gly
Lys Thr Gly Glu
Lys Val Gly Met
Lys Val Met Gly
Leu Ala Cys Lys
Leu Ala Lys Cys
Leu Cys Ala Lys
Leu Cys Lys Ala
Leu Lys Ala Cys
Leu Lys Cys Ala
Leu Asn Ser Thr
Leu Asn Thr Ser
Leu Gln Ser Ser
Leu Ser Asn Thr
Leu Ser Gln Ser
Leu Ser Ser Gln
Leu Ser Thr Asn
Leu Thr Asn Ser
Leu Thr Ser Asn
Met Ala Gly Arg
Met Ala Arg Gly
Met Gly Ala Arg
Met Gly Lys Val
Met Gly Arg Ala
Met Gly Val Lys
Met Lys Gly Val
Met Lys Val Gly
Met Arg Ala Gly
Met Arg Gly Ala
Met Val Gly Lys
Met Val Lys Gly
Asn Ile Ser Thr
Asn Ile Thr Ser
Asn Leu Ser Thr
Asn Leu Thr Ser
Asn Ser Ile Thr
Asn Ser Leu Thr
Asn Ser Thr Ile
Asn Ser Thr Leu
Asn Thr Ile Ser
Asn Thr Leu Ser
Asn Thr Ser Ile
Asn Thr Ser Leu
Asn Thr Thr Val
Asn Thr Val Thr
Asn Val Thr Thr
Gln Ile Ser Ser
Gln Leu Ser Ser
Gln Ser Ile Ser
Gln Ser Leu Ser
Gln Ser Ser Ile
Gln Ser Ser Leu
Gln Ser Thr Val
Gln Ser Val Thr
Gln Thr Ser Val
Gln Thr Val Ser
Gln Val Ser Thr
Gln Val Thr Ser
Arg Ala Gly Met
Arg Ala Met Gly
Arg Ala Ser Thr
Arg Ala Thr Ser
Arg Cys Gly Val
Arg Cys Val Gly
Arg Gly Ala Met
Arg Gly Cys Val
Arg Gly Met Ala
Arg Gly Thr Thr
Arg Gly Val Cys
Arg Met Ala Gly
Arg Met Gly Ala
Arg Ser Ala Thr
Arg Ser Thr Ala
Arg Thr Ala Ser
Arg Thr Gly Thr
Arg Thr Ser Ala
Arg Thr Thr Gly
Arg Val Cys Gly
Arg Val Gly Cys
Ser Ala Glu Lys
Ser Ala Lys Glu
Ser Ala Arg Thr
Ser Ala Thr Arg
Ser Glu Ala Lys
Ser Glu Lys Ala
Ser Ile Asn Thr
Ser Ile Gln Ser
Ser Ile Ser Gln
Ser Ile Thr Asn
Ser Lys Ala Glu
Ser Lys Glu Ala
Ser Leu Asn Thr
Ser Leu Gln Ser
Ser Leu Ser Gln
Ser Leu Thr Asn
Ser Asn Ile Thr
Ser Asn Leu Thr
Ser Asn Thr Ile
Ser Asn Thr Leu
Ser Gln Ile Ser
Ser Gln Leu Ser
Ser Gln Ser Ile
Ser Gln Ser Leu
Ser Gln Thr Val
Ser Gln Val Thr
Ser Arg Ala Thr
Ser Arg Thr Ala
Ser Ser Ile Gln
Ser Ser Leu Gln
Ser Ser Gln Ile
Ser Ser Gln Leu
Ser Thr Ala Arg
Ser Thr Ile Asn
Ser Thr Leu Asn
Ser Thr Asn Ile
Ser Thr Asn Leu
Ser Thr Gln Val
Ser Thr Arg Ala
Ser Thr Val Gln
Ser Val Gln Thr
Ser Val Thr Gln
Thr Ala Asp Lys
Thr Ala Lys Asp
Thr Ala Arg Ser
Thr Ala Ser Arg
Thr Asp Ala Lys
Thr Asp Lys Ala
Thr Glu Gly Lys
Thr Glu Lys Gly
Thr Gly Glu Lys
Thr Gly Lys Glu
Thr Gly Arg Thr
Thr Gly Thr Arg
Thr Ile Asn Ser
Thr Ile Ser Asn
Thr Lys Ala Asp
Thr Lys Asp Ala
Thr Lys Glu Gly
Thr Lys Gly Glu
Thr Leu Asn Ser
Thr Leu Ser Asn
Thr Asn Ile Ser
Thr Asn Leu Ser
Thr Asn Ser Ile
Thr Asn Ser Leu
Thr Asn Thr Val
Thr Asn Val Thr
Thr Gln Ser Val
Thr Gln Val Ser
Thr Arg Ala Ser
Thr Arg Gly Thr
Thr Arg Ser Ala
Thr Arg Thr Gly
Thr Ser Ala Arg
Thr Ser Ile Asn
Thr Ser Leu Asn
Thr Ser Asn Ile
Thr Ser Asn Leu
Thr Ser Gln Val
Thr Ser Arg Ala
Thr Ser Val Gln
Thr Thr Gly Arg
Thr Thr Asn Val
Thr Thr Arg Gly
Thr Thr Val Asn
Thr Val Asn Thr
Thr Val Gln Ser
Thr Val Ser Gln
Thr Val Thr Asn
Val Cys Gly Arg
Val Cys Arg Gly
Val Gly Cys Arg
Val Gly Lys Met
Val Gly Met Lys
Val Gly Arg Cys
Val Lys Gly Met
Val Lys Met Gly
Val Met Gly Lys
Val Met Lys Gly
Val Asn Thr Thr
Val Gln Ser Thr
Val Gln Thr Ser
Val Arg Cys Gly
Val Arg Gly Cys
Val Ser Gln Thr
Val Ser Thr Gln
Val Thr Asn Thr
Val Thr Gln Ser
Val Thr Ser Gln
Val Thr Thr Asn
Dextrorphan O-glucuronide
Hericenone B
2-[[(9H-Fluoren-9-ylmethoxy)carbonyl]amino]-2-(4-penten-1-yl)-6-heptenoic acid
TERT-BUTYL 4-(2-NITRO-4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERAZINE-1-CARBOXYLATE
Ethanone, 1-[3-ethyl-4-(hydroxymethyl)phenyl]-,O-[[4-cyclohexyl-3-(trifluoromethyl)phenyl]methyl]oxime, (1E)-
1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-
(R)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
COVID info from PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(7R)-7-[[3,6-Dideoxy-4-O-(1H-indol-3-ylcarbonyl)-alpha-L-arabino-hexopyranosyl]oxy]octanoic acid
(S)-N-(4-(tert-Butyl)phenyl)-N-(2-(tert-butylamino)-2-oxo-1-(pyridin-3-yl)ethyl)furan-2-carboxamide
6-[[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]methyl]-N2-(3-methylphenyl)-1,3,5-triazine-2,4-diamine
{1-[2-(1-Formyl-propyl)-3-methanesulfonylamino-pyrrolidine-1-carbonyl]-2-methyl-propyl}-carbamic acid tert-butyl ester
Ethyl 3-[7-(diaminomethyl)naphthalen-2-yl]-2-(4-pyrrolidin-3-yloxyphenyl)propanoate
Ricolinostat
D004791 - Enzyme Inhibitors > D056572 - Histone Deacetylase Inhibitors C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent D000970 - Antineoplastic Agents
Levallorphan Tartrate
C78272 - Agent Affecting Nervous System > C681 - Opiate Antagonist
(13S)-7-hydroxy-12,12-dimethyl-8-(3-methylbut-2-enyl)-10,19,21-triazahexacyclo[13.5.2.01,13.03,11.04,9.015,19]docosa-3(11),4(9),5,7-tetraene-20,22-dione
(Z)-1-[4-(4-Diethylaminobutoxy)phenyl]-1,2-diphenyl-2-chloro-ethylene
1-Hydroxyprotostemonine, (rel)-
A natural product found in Stemona curtisii.
3,4-Dimethoxybenzaldehyde [4-anilino-6-(1-piperidinyl)-1,3,5-triazin-2-yl]hydrazone
N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-N-ethyl-2-(2-methyl-2,3-dihydroindol-1-yl)acetamide
3-[(2E,4E,8S,10E,12Z)-4,8-dimethyltetradeca-2,4,10,12-tetraenoyl]-4-hydroxy-5-(4-hydroxyphenyl)-1,2-dihydropyridin-2-one
(8R,9S,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10R)-9-[4-[(3S)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10R)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8R,9S,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(8S,9R,10S)-9-[4-[(3R)-3-hydroxybut-1-ynyl]phenyl]-10-(hydroxymethyl)-N-phenyl-1,6-diazabicyclo[6.2.0]decane-6-carboxamide
(2S,3S,3aR,9bR)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-N-(2,3-dihydro-1H-inden-2-yl)-1-ethyl-3-(hydroxymethyl)-6-oxo-7-[(E)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
(1S,9R,10R,11R)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
(1R,9S,10S,11S)-11-(3,4-dihydro-1H-isoquinoline-2-carbonyl)-12-ethyl-10-(hydroxymethyl)-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-dien-6-one
3-[2-[2-benzyl-6-[(3R,4R)-3-hydroxy-4-methoxypyrrolidin-1-yl]pyridin-3-yl]ethynyl]-1-azabicyclo[2.2.2]octan-3-ol
Mycophenolate Mofetil
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C471 - Enzyme Inhibitor > C2087 - Inosine Monophosphate Dehydrogenase Inhibitor C308 - Immunotherapeutic Agent > C574 - Immunosuppressant D000970 - Antineoplastic Agents D004791 - Enzyme Inhibitors